Orchid Chemicals & Pharmaceuticals Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Orchid Chemicals & Pharmaceuticals Ltd Announces Extension Of Financial Year For 2012-2013 Up To 18 Months
Orchid Chemicals & Pharmaceuticals Ltd announced that the Board of Directors of the Company through circular resolution passed on June 24, 2013 have approved the extension of financial year 2012-2013 of the Company by a further period of 3 (three) months i.e. upto September 30, 2013.
Latest Developments forOrchid Chemicals & Pharmaceuticals Ltd
Latest Key Developments inPharmaceuticals
- AbbVie Inc extends exchange offer to acquire Pharmacyclics, Inc.
- Celgene Corp announces analysis of REVLIMID (Lenalidomide) in patients with non-del-5Q MDS demonstrated improved health related quality of life measures
- Cambrex Corp reaffirms FY 2015 outlook
- Pernix Therapeutics Holdings Inc gives FY 2015 guidance
- Share this
- Digg this